Tailoring the number of consults based on HF severity, which can be assessed pragmatically, could pay dividends, say ...

The results have implications not only for resource-limited parts of the world, but also for wealthier countries, one expert ...

As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of ...

While the results bolster efficacy, questions remain about high costs and other issues with the ATTR-CM therapies.

STEMI criteria alone aren’t perfect for identifying occluded arteries, but still some question the need for a new paradigm.